BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park J, Lee SH, You SC, Kim J, Yang K. Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19. Sci Rep 2021;11:5087. [PMID: 33658615 DOI: 10.1038/s41598-021-84539-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Metwally RA, El-Sersy NA, El Sikaily A, Sabry SA, Ghozlan HA. Optimization and multiple in vitro activity potentials of carotenoids from marine Kocuria sp. RAM1. Sci Rep 2022;12:18203. [PMID: 36307503 DOI: 10.1038/s41598-022-22897-4] [Reference Citation Analysis]
2 Kushner P, McCarberg BH, Grange L, Kolosov A, Haveric AL, Zucal V, Petruschke R, Bissonnette S. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim Care Respir Med 2022;32:35. [PMID: 36127354 DOI: 10.1038/s41533-022-00300-z] [Reference Citation Analysis]
3 Kanapeckaitė A, Mažeikienė A, Geris L, Burokienė N, Cottrell GS, Widera D. Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises. Biophys Chem 2022;290:106891. [PMID: 36137310 DOI: 10.1016/j.bpc.2022.106891] [Reference Citation Analysis]
4 Zhou Q, Zhao S, Gan L, Wang Z, Peng S, Li Q, Liu H, Liu X, Wang Z, Shi Q, Estill J, Luo Z, Wang X, Liu E, Chen Y. Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine 2022;46:101373. [PMID: 35434582 DOI: 10.1016/j.eclinm.2022.101373] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sokolowska M, Rovati GE, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, Sava F, Angelina A, Palomares O, Akdis C, O'Mahony L, Jesenak M, Pfaar O, Torres MJ, Sanak M, Dahlén SE, Woszczek G. Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19. Allergy 2022. [PMID: 35174512 DOI: 10.1111/all.15258] [Reference Citation Analysis]
6 Ioele G, Grande F, De Luca M, Occhiuzzi MA, Garofalo A, Ragno G. Photodegradation of Anti-Inflammatory Drugs: Stability Tests and Lipid Nanocarriers for Their Photoprotection. Molecules 2021;26:5989. [PMID: 34641532 DOI: 10.3390/molecules26195989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Salva O, Alasino R, Giller C, Borello J, Doresky A, Karayan G, Beltramo D. Nebulization with alkaline hipertonic ibuprofen induces a rapid increase in platelets circulating in COVID-19 patients but not in healthy subjects. Platelets 2021;:1-8. [PMID: 34423724 DOI: 10.1080/09537104.2021.1967918] [Reference Citation Analysis]
8 Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID-19: A Systematic Review and Meta-analysis. Drug Saf 2021;44:929-38. [PMID: 34339037 DOI: 10.1007/s40264-021-01089-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
9 Kow CS, Hasan SS. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology 2021;29:641-4. [PMID: 33881684 DOI: 10.1007/s10787-021-00810-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
10 Puccetti M, Costantini C, Ricci M, Giovagnoli S. Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics. Pharmaceutics 2021;13:494. [PMID: 33916409 DOI: 10.3390/pharmaceutics13040494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]